Science Explorer Interactive view Map
Company · Schiphol-Rijk · Netherlands

Merck B.V. (Netherlands)

merckgroup.comROR OpenAlex
Research works
63
▼ 72% vs 2013–17
Citations
2.9k
45.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Merck B.V. (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.51× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.37× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.96× its world share, 0 worksImmunology and Micro…Mathematics: 4.35× its world share, 0 worksMathematicsMedicine: 2.63× its world share, 1 worksMedicineDecision Sciences: 2.64× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.67× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.4×. Every wedge is a field page.

Which keywords describe research at Merck B.V. (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cardiovascular Disease, Metabolic Syndrome, Cancer Therapy, Cancer, Hypertension, Angiogenesis and Signal Transduction.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 3.9×27 topics
  2. Cardiovascular Disease4▲ 5.8×10 topics
  3. Cancer4▲ 4.5×17 topics
  4. Metabolic Syndrome4▲ 6.7×10 topics
  5. Cancer Therapy3▲ 8.1×7 topics
  6. Angiogenesis2▲ 8.9×7 topics
  7. Hypertension2▲ 10×5 topics
  8. Drug Discovery2▲ 8.8×5 topics
  9. Infertility2▲ 25×3 topics
  10. Obesity2▲ 4.7×7 topics
  11. Signal Transduction2▲ 14×2 topics
  12. Medicinal Chemistry2▲ 9.1×5 topics
  13. Oncogenic Mutations2▲ 73×2 topics
  14. Transcriptional Regulation2▲ 13×4 topics
  15. Cell Proliferation2▲ 36×2 topics
  16. Insulin Resistance2▲ 7.0×4 topics
  17. Therapeutic Targets2▲ 14×5 topics
  18. Immune Response2▲ 4.9×7 topics
  19. Chemotherapy2▲ 3.9×10 topics
  20. Clinical Guidelines2▲ 8.5×4 topics
  21. Anticancer Agents2▲ 10×4 topics
  22. Cell Migration2▲ 31×3 topics
  23. Cell Signaling2▲ 7.8×4 topics
  24. Fertility2▲ 29×2 topics
  25. Pharmacokinetics2▲ 9.5×3 topics
  26. Cytochrome P4502▲ 33×2 topics
  27. Ovarian Reserve2▲ 55×1 topic
  28. Pharmacology2▲ 7.3×4 topics
  29. Polycystic Ovary Syndrome2▲ 55×1 topic
  30. Cardiovascular Events1▲ 14×3 topics
  31. Fertility Preservation1▲ 31×1 topic
  32. Metastasis1▲ 6.7×7 topics
  33. Ovarian Tissue Cryopreservation1▲ 31×1 topic
  34. BRAF gene1▲ 117×1 topic
  35. Breast Cancer1▲ 7.2×3 topics
  36. Cognitive Impairment1▲ 8.7×4 topics
  37. MAP Kinase1▲ 117×1 topic
  38. Melanoma1▲ 42×2 topics
  39. Glycosylation1▲ 8.5×3 topics
  40. Osteoblast Differentiation1▲ 41×2 topics

Which research topics does Merck B.V. (Netherlands) publish most on?

By volume in 2022–2025: Bioeconomy and Sustainability Development, Viral Infectious Diseases and Gene Expression in Insects, Biotechnology and Related Fields and Chromosomal and Genetic Variations.

Bioeconomy and Sustainab…0Bioeconomy and Sustainability Development: 0 fractional worksViral Infectious Disease…0Viral Infectious Diseases and Gene Expression in Insects: 0 fractional worksBiotechnology and Relate…0Biotechnology and Related Fields: 0 fractional worksChromosomal and Genetic …0Chromosomal and Genetic Variations: 0 fractional worksRheumatoid Arthritis Research and Therapies: 0 fractional worksMultiple Sclerosis Research Studies: 0 fractional worksEconomic and Financial I…0Economic and Financial Impacts of Cancer: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksAcute Lymphoblastic Leukemia research: 0 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional works
General Agricultural and Biological SciencesMolecular BiologyPublic Health, Environmental and Occupational HealthPlant Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bioeconomy and Sustainability Development General Agricultural and Biological Sciences 0 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  3. 3 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 0 works
  4. 4 Chromosomal and Genetic Variations Plant Science 0 works
  5. 5 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  6. 6 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  8. 8 Bladder and Urothelial Cancer Treatments Surgery 0 works
  9. 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
  10. 10 CRISPR and Genetic Engineering Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.6%not open48.4%

World: 28% of research is openly available.

with international co-authors55.9%domestic only44.1%

World: 19% is written across borders.

How has Merck B.V. (Netherlands)'s research output changed?

Output in 2018–2022 was 72% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.